What is a developmental venous anomaly (DVA) in the left frontal lobe?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is a Developmental Venous Anomaly in the Left Frontal Lobe?

A developmental venous anomaly (DVA) in the left frontal lobe is a benign congenital variant of normal venous drainage—not a true malformation—consisting of dilated medullary veins that converge into a single collecting vessel, draining normal brain parenchyma. 1, 2

Definition and Anatomical Structure

  • DVAs represent extreme anatomical variations of medullary veins rather than pathological malformations, characterized by radially arranged veins converging centripetally into an enlarged collector vein with a characteristic "caput medusae" (head of Medusa) appearance on imaging 3, 4

  • The frontal lobe is the most common supratentorial location for DVAs, accounting for approximately 35% of all DVAs 5

  • These anomalous veins drain into either superficial cerebral veins (most commonly, in 68.78% of cases) or the deep venous system 5

  • DVAs are the most frequently encountered cerebral vascular malformations, with a prevalence of approximately 7.5% in adult populations on MRI studies 5

Clinical Significance and Natural History

DVAs are overwhelmingly benign and asymptomatic, requiring only conservative observation without surgical or endovascular intervention. 2

  • The previously reported high incidence of hemorrhage associated with DVAs is now attributed to coexisting cavernous malformations rather than the DVA itself 1, 4

  • Approximately 20% of DVAs coexist with cavernomas, and when this association exists, the annual hemorrhage risk increases to 3.3-4.5% due to the cavernoma, not the DVA 1, 2

  • Isolated DVAs without associated cavernomas are considered benign variants with minimal risk of complications 2, 3

Imaging Characteristics

  • MRI is the imaging modality of choice for evaluating DVAs, with contrast enhancement increasing conspicuity of the anomalous venous structures 1

  • DVAs appear as clusters of veins draining into a single collector vessel, visible on both spin-echo and gradient-echo sequences 1

  • T2-weighted gradient-echo imaging or susceptibility-weighted imaging (SWI) is essential to detect any coexisting cavernomas that may be invisible on conventional spin-echo sequences 1, 6

  • Catheter angiography shows DVAs only during the venous phase as an abnormal cluster of veins, appearing angiographically occult during arterial phases 1

Critical Management Principles

The definitive recommendation is conservative clinical observation without intervention for asymptomatic, incidentally discovered DVAs. 2

  • Surgical or endovascular treatment of isolated DVAs is contraindicated because these vessels represent the only venous drainage pathway for normal brain parenchyma; disrupting them can cause venous infarction 3, 4

  • The primary management concern is identifying any associated cavernoma using high-resolution MRI with gradient-echo or SWI sequences 1, 6

  • If a coexisting cavernoma is detected, management shifts to monitoring the cavernoma rather than the DVA itself 6

Important Pitfalls and Caveats

  • Do not confuse DVAs with high-flow vascular malformations (arteriovenous malformations or fistulas), which require entirely different therapeutic strategies 2

  • Rare complications can occur, including spontaneous thrombosis of the DVA collector vein leading to venous infarction, though this is exceedingly uncommon 7

  • Some DVAs may demonstrate surrounding brain parenchymal signal abnormalities on FLAIR sequences (approximately 5% of cases), likely representing venous congestion, but this does not change management 3, 5

  • The prevalence of DVAs decreases with age, suggesting some may undergo spontaneous involution over time 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Incidentally Discovered Asymptomatic Cerebellar Developmental Venous Anomalies

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Developmental Venous Anomaly: Benign or Not Benign.

Neurologia medico-chirurgica, 2016

Guideline

Management of Incidentally Found Cavernomas

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the management plan for a patient with a probable small incidental developmental venous anomaly (DVA) in the right parietal lobe found on MRI?
What is the appropriate management for an incidental, asymptomatic cerebellar developmental venous anomaly?
What is the appropriate management for a patient with a gross anomaly of venous drainage in the left cerebellar region?
In an asymptomatic adult with a left frontal lobe developmental venous anomaly and a 4‑mm superiorly projecting saccular aneurysm of the left supraclinoid internal carotid artery, what is the recommended management?
Can a developmental venous anomaly (DVA) cause symptoms?
How does sertraline act as both a substrate and a modulator of P‑glycoprotein (P‑gp), and what are the clinical implications?
What is the recommended diagnostic workup and first‑line treatment for multiple myeloma, including options for transplant‑eligible and transplant‑ineligible patients?
What is the recommended evaluation and management for communicating hydrocephalus?
What is the recommended dosing interval for lisdexamfetamine and what dietary recommendations should be followed while taking it?
How should I taper and discontinue aripiprazole (Abilify) in a depressed patient taking metoprolol, bupropion (Wellbutrin), clonidine, a proton‑pump inhibitor for reflux, and an unidentified anxiety medication?
In an adult with severe opioid intoxication, can naloxone precipitate acute non‑cardiogenic pulmonary edema, and how should its dosing and subsequent management be handled?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.